Janus Henderson Group
BNTX icon

Janus Henderson Group’s BioNTech BNTX Stock Holding History

Janus Henderson Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-51,456
Closed -$12.6M – 2661
2021
Q4 		$12.6M Buy
+51,456
New +$14.1M 0.01% 874
2021
Q3 		– Sell
-54,981
Closed -$12.4M – 2197
2021
Q2 		$12.4M Sell
54,981
-91,372
-62% -$17.2M 0.01% 900
2021
Q1 		$15.7M Buy
146,353
+137,180
+1,495% +$14.6M 0.01% 822
2020
Q4 		$748K Sell
9,173
-802,295
-99% -$78.8M ﹤0.01% 1230
2020
Q3 		$56.2M Sell
811,468
-357,665
-31% -$25.7M 0.03% 471
2020
Q2 		$78M Buy
+1,169,133
New +$58.4M 0.04% 375

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group's BNTX Position: Q1 2022 in Review

Janus Henderson Group sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 51,456 shares — an estimated $12.6M sold.

Janus Henderson Group first reported a position in BNTX in Q2 2020 and held it in 6 quarters. The position peaked at $78M in Q2 2020. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Janus Henderson Group reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Janus Henderson Group sold 51,456 BioNTech shares in Q1 2022, an estimated $12.6M.
  • Janus Henderson Group first reported a position in BioNTech in Q2 2020 and held it in 6 quarters.
  • Janus Henderson Group's BioNTech position peaked at $78M in Q2 2020.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.